Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03591107 · ClinicalTrials.gov registry record · NA

Trauma-informed Collaborative Care for Low-income African Americans With PTSD

A NA study, sponsored by RAND.

Completed
Registry status
NA
Development phase
42
Enrollment target

NCT03591107: Completed NA study, sponsored by RAND.

NCT03591107 is a NA study that has completed, run by RAND. The registered enrollment target is 42 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03591107, a NA study, has completed, sponsored by RAND.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target

Study Summary

The purpose of this study is to optimize, culturally adapt, implement, and pilot test a trauma-informed collaborative care intervention for low-income African Americans who receive care in Federally Qualified Health Centers (FQHCs) in New Orleans, Louisiana. We will randomize 40 patients to either a Posttraumatic Stress Disorder (PTSD) collaborative care intervention or to an enhanced usual care control and will evaluate the effectiveness of the intervention (including whether outcome expectancy, coping efficacy, and trust mediate the impact of the intervention) as well as its feasibility, tolerability, and acceptability.

Primary Outcome

total count of 20 PTSD symptom ratings on the 0-4 PTSD Checklist for DSM-5 (PCL-5), range = 0=80, higher scores mean a worse outcome

Interventions

  • OTHER PTSD Care Management (PCM)
  • OTHER Minimally Enhanced Usual Care (MEU)

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2018-10-12
Est. Completion 2020-03-30
Phase NA
RAND

78 total trials

What the finished NCT03591107 record still lists

NCT03591107 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 42 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which PTSD Care Management (PCM) is the first listed.

NCT03591107 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03591107 about?

NCT03591107 is a clinical study titled "Trauma-informed Collaborative Care for Low-income African Americans With PTSD". The purpose of this study is to optimize, culturally adapt, implement, and pilot test a trauma-informed collaborative care intervention for low-income African Americans who receive care in Federally Qualified Health Centers (FQHCs) in New Orleans, Louisiana. We will randomize 40 patients to either a...

What is the current status of trial NCT03591107?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2018-10-12. Estimated completion is 2020-03-30.

What interventions are being tested in trial NCT03591107?

The interventions under investigation include: PTSD Care Management (PCM) (OTHER), Minimally Enhanced Usual Care (MEU) (OTHER).

Who is sponsoring clinical trial NCT03591107?

This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03591107's enrollment target sits among peer trials

42 1436th of 2000 higher than 555 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02852213 · 42 participants · Phase 1

    A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

  • NCT03136146 · 42 participants · Phase 2

    Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia

  • NCT03178149 · 42 participants · Phase 1

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

  • NCT03663530 · 42 participants · NA

    Circadian Misalignment and Energy Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03591107, the US trial registry maintained by the National Library of Medicine. NCT03591107 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.